Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Joss

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 7, 2000
A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase bindingC A Akdis, A Joss, M Akdis, et al.
Lancet (London, England)|May 1, 1982
Sudden death in cancer patient on high-dose domperidoneR A Joss, A Goldhirsch, K W Brunner, et al.
Schweizerische Medizinische Wochenschrift|September 7, 1991
[Syndrome of inappropriate ADH secretion (SIADH) in small-cell bronchus carcinoma]A von Rohr, T Cerny, R A Joss, et al.
Patologia Polska|July 1, 1977
[Comparison between physiological and morphological examinations of animal livers maintained in hypothermia and perfused with Collins solution]L Woźniak, A Joss, T Sassulicz-Piatek, et al.
European Journal of Immunology|July 18, 2000
IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathwayA Joss, M Akdis, A Faith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The symptomatic control of cytostatic drug-induced emesis. A recent history and reviewR A Joss, B C Brand, K S Buser, et al.
Oral Microbiology and Immunology|March 1, 1987
Longitudinal clinical and microbiological study on the relationship between infection with Streptococcus mutans and the development of caries in humansN P Lang, P R Hotz, F A Gusberti, et al.
Medical and Pediatric Oncology|January 1, 1981
Lung abscesses following corticosteroid therapy for central nervous system metastasesR A Joss, R S Goldberg, J W Yates, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungR A Joss, H H Hansen, M Hansen, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Alizapride, a new substituted benzamide, as an antiemetic during cancer chemotherapyR A Joss, R L Galeazzi, A K Bischoff, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 7, 2000
A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase bindingC A Akdis, A Joss, M Akdis, et al.
Lancet (London, England)|May 1, 1982
Sudden death in cancer patient on high-dose domperidoneR A Joss, A Goldhirsch, K W Brunner, et al.
Schweizerische Medizinische Wochenschrift|September 7, 1991
[Syndrome of inappropriate ADH secretion (SIADH) in small-cell bronchus carcinoma]A von Rohr, T Cerny, R A Joss, et al.
Patologia Polska|July 1, 1977
[Comparison between physiological and morphological examinations of animal livers maintained in hypothermia and perfused with Collins solution]L Woźniak, A Joss, T Sassulicz-Piatek, et al.
European Journal of Immunology|July 18, 2000
IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathwayA Joss, M Akdis, A Faith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The symptomatic control of cytostatic drug-induced emesis. A recent history and reviewR A Joss, B C Brand, K S Buser, et al.
Oral Microbiology and Immunology|March 1, 1987
Longitudinal clinical and microbiological study on the relationship between infection with Streptococcus mutans and the development of caries in humansN P Lang, P R Hotz, F A Gusberti, et al.
Medical and Pediatric Oncology|January 1, 1981
Lung abscesses following corticosteroid therapy for central nervous system metastasesR A Joss, R S Goldberg, J W Yates, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungR A Joss, H H Hansen, M Hansen, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Alizapride, a new substituted benzamide, as an antiemetic during cancer chemotherapyR A Joss, R L Galeazzi, A K Bischoff, et al.
Pageof 15